Bioworkshops sell "Disitamab Vedotin"
Basic Information
718
40
4
3.5(65)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Disitamab Vedotin
Manufacturer(s)
Specifications
- Regulatory Status: Approved in China on June 8, 2021, chiefly for HER2-positive gastric cancer, alongside other neoplastic, digestive, dermatological and musculoskeletal indications
- Application: HER2-targeted antibody-drug conjugate combining a monoclonal antibody HER2 antagonist with a tubulin-inhibitor payload (CAS 2185868-98-6)
- Country of Origin: China (RemeGen Co., Ltd.)
- Purity: High degree of analytical comparability to the reference product, demonstrated through comprehensive analytical characterization, developed from a cell line with DMF filing
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment